| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 322.071 | 88 |
| GSM780708 | Untreated after 4 days (C2_1) | 358.03 | 89 |
| GSM780709 | Untreated after 4 days (C3_1) | 300.165 | 87 |
| GSM780719 | Untreated after 4 days (C1_2) | 359.403 | 89 |
| GSM780720 | Untreated after 4 days (C2_2) | 266.461 | 86 |
| GSM780721 | Untreated after 4 days (C3_2) | 304.458 | 88 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 353.322 | 89 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 310.904 | 88 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 377.469 | 89 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 404.666 | 90 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 282.652 | 87 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 294.616 | 87 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 339.738 | 88 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 387.916 | 90 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 298.691 | 87 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 307.534 | 88 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 321.154 | 88 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 317.946 | 88 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 206.947 | 84 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 325.392 | 88 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 271.362 | 87 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 304.378 | 88 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 289.375 | 87 |